fashion -WSS

fashion

author：hotspot 2025-09-30 16:26:43 - browse：36

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： A timeline of the missing Titanic tourist submersible

WSS

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Australia’s approach to dialysis celebrates life

Winners, losers from Medicare’s list of drugs subject to price talks

In science, is the line between industry and academia shifting?

How a symptom of dementia informs our understanding of creativity

Some in Scotland's Orkney Islands want to return to Norway after 550 years

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Departing Stanford president retracts two papers

ChatGPT in medicine: STAT answers readers' burning questions

Australia’s approach to dialysis celebrates life

Duchenne breakthrough therapy leaves behind pioneering families

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

New air purifier tech could be key to improving indoor air quality

Why more medical students aren't specializing in primary care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

leisure time

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

NASA releases new images of 'fingerprint

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

NYU Langone launches private ChatGPT for its health care data

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

EU climate chief is concerned over the expansion of the coal industry in China

focus

knowledge

focus

hotspot